Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

NCT: NCT05879913 · RECRUITING

NCT IDNCT05879913
StatusRECRUITING
Start Date2023-12-15
Completion2028-07
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

This is a randomized pilot study of Coronary CT Angiography (CCTA) for coronary atherosclerosis vs. Usual Care in patients with prostate cancer who are either planning to begin, or are currently taking androgen deprivation therapy (ADT) .

Frequently Asked Questions

What is ASCVD Management Using CCTA in Prostate Cancer Patients on ADT?

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT is a clinical trial registered under NCT05879913. Current status: RECRUITING.

What is the status of NCT05879913?

The current status of NCT05879913 (ASCVD Management Using CCTA in Prostate Cancer Patients on ADT) is: RECRUITING.

When did ASCVD Management Using CCTA in Prostate Cancer Patients on ADT start?

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT started on 2023-12-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑